664 related articles for article (PubMed ID: 27236360)
1. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.
Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2016 Aug; 160(2):306-17. PubMed ID: 27236360
[TBL] [Abstract][Full Text] [Related]
2. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
[TBL] [Abstract][Full Text] [Related]
3. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
4. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
Chari ST; Yadav D; Smyrk TC; DiMagno EP; Miller LJ; Raimondo M; Clain JE; Norton IA; Pearson RK; Petersen BT; Wiersema MJ; Farnell MB; Sarr MG
Gastroenterology; 2002 Nov; 123(5):1500-7. PubMed ID: 12404225
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
Date K; Ohtsuka T; Nakamura S; Mochidome N; Mori Y; Miyasaka Y; Oda Y; Nakamura M
Surgery; 2018 Feb; 163(2):291-299. PubMed ID: 29221879
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.
Yogi T; Hijioka S; Imaoka H; Mizuno N; Hara K; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Niwa Y; Yoshimura K; Bhatia V; Fujita J; Yamao K
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):757-65. PubMed ID: 26148131
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
[TBL] [Abstract][Full Text] [Related]
8. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
[TBL] [Abstract][Full Text] [Related]
9. Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II cohort study.
Moriya T; Traverso W
Arch Surg; 2012 Jun; 147(6):528-34. PubMed ID: 22351878
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.
Xourafas D; Tavakkoli A; Clancy TE; Ashley SW
Surgery; 2015 Mar; 157(3):473-83. PubMed ID: 25596773
[TBL] [Abstract][Full Text] [Related]
12. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary mucinous neoplasms of the pancreas: CT patterns of recurrence and multiobserver performance in detecting recurrent neoplasm after surgical resection.
Christensen JA; Fletcher JG; Fidler JL; Wold PB; Binstock AJ; Smyrk T; Harmsen SW; Crownhart BS; Chari S
AJR Am J Roentgenol; 2004 Nov; 183(5):1367-74. PubMed ID: 15505305
[TBL] [Abstract][Full Text] [Related]
14. Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
Winter JM; Jiang W; Basturk O; Mino-Kenudson M; Fong ZV; Tan WP; Lavu H; Vollmer CM; Furth EE; Haviland D; Klimstra DS; Jarnagin WR; Lillemoe KD; Yeo CJ; Fernandez-Del Castillo C; Allen PJ
Ann Surg; 2016 Apr; 263(4):793-801. PubMed ID: 26135696
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
[TBL] [Abstract][Full Text] [Related]
16. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.
Fujii T; Kato K; Kodera Y; Kanda M; Nagai S; Yamada S; Kanzaki A; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakamura S; Nakao A
Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
[TBL] [Abstract][Full Text] [Related]
19. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm.
White R; D'Angelica M; Katabi N; Tang L; Klimstra D; Fong Y; Brennan M; Allen P
J Am Coll Surg; 2007 May; 204(5):987-93; discussion 993-5. PubMed ID: 17481526
[TBL] [Abstract][Full Text] [Related]
20. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
